.Pharmacolibrary.Drugs.ATC.R.R03AC12 .Pharmacolibrary.Drugs.ATC.R.R03AC12| name: | Salmeterol |
| ATC code: | R03AC12 | route: | inhalation |
| n-compartments | 2 |
Salmeterol is a long-acting beta-2 adrenergic agonist (LABA) used as a bronchodilator for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It is used in combination with inhaled corticosteroids for asthma and as monotherapy or combination in COPD. Salmeterol is currently approved and widely used for these indications.
Pharmacokinetic parameters reported in healthy adult volunteers following inhalation administration.
Soulele, K, et al., & Karalis, V (2015). Population pharmacokinetics of fluticasone propionate/salmeterol using two different dry powder inhalers. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 80 33–42. DOI:10.1016/j.ejps.2015.08.009 PUBMED:https://pubmed.ncbi.nlm.nih.gov/26296862
Li, S, et al., & Gobburu, JVS (2024). Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol Xinafoate to Quantify Batch-to-Batch Variability. The AAPS journal 26(3) 56–None. DOI:10.1208/s12248-024-00913-x PUBMED:https://pubmed.ncbi.nlm.nih.gov/38671158
Xu, J, et al., & Derendorf, H (2010). Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma. Journal of clinical pharmacology 50(10) 1118–1127. DOI:10.1177/0091270009354994 PUBMED:https://pubmed.ncbi.nlm.nih.gov/20150524